What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Cardiology
Steven E. Nissen mainly investigates Internal medicine, Cardiology, Intravascular ultrasound, Coronary artery disease and Surgery.
Many of his studies involve connections with topics such as Placebo and Internal medicine.
His work carried out in the field of Cardiology brings together such families of science as Blood pressure and Vascular disease.
The Intravascular ultrasound study combines topics in areas such as Lesion, Lumen, Transplantation and Surrogate endpoint.
His studies deal with areas such as Pravastatin and C-reactive protein as well as Coronary artery disease.
His Surgery study combines topics from a wide range of disciplines, such as Acute coronary syndrome, Weight loss and Type 2 diabetes.
His most cited work include:
- Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes (3917 citations)
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (3062 citations)
- American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS) (1831 citations)
What are the main themes of his work throughout his whole career to date?
Steven E. Nissen focuses on Internal medicine, Cardiology, Intravascular ultrasound, Coronary artery disease and Radiology.
In his study, Surgery is inextricably linked to Diabetes mellitus, which falls within the broad field of Internal medicine.
His research integrates issues of Blood pressure and Cholesterol in his study of Cardiology.
His Intravascular ultrasound research integrates issues from Coronary arteries, Vascular disease, Rosuvastatin, Lumen and Transplantation.
As a member of one scientific family, Steven E. Nissen mostly works in the field of Coronary artery disease, focusing on Atorvastatin and, on occasion, Pravastatin.
His study in Angiography and Ultrasound is carried out as part of his Radiology studies.
He most often published in these fields:
- Internal medicine (64.68%)
- Cardiology (48.29%)
- Intravascular ultrasound (27.72%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (64.68%)
- Cardiology (48.29%)
- Diabetes mellitus (10.88%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Cardiology, Diabetes mellitus, Coronary artery disease and Randomized controlled trial.
His research on Internal medicine often connects related topics like Placebo.
His Cardiology research is multidisciplinary, incorporating perspectives in Evolocumab and Lipoprotein.
His Diabetes mellitus research is multidisciplinary, relying on both Obesity and Surgery.
His Myocardial infarction research incorporates themes from Stroke, C-reactive protein and Hazard ratio.
His work on Glycated hemoglobin as part of general Type 2 diabetes research is often related to Sleeve gastrectomy and Alogliptin, thus linking different fields of science.
Between 2015 and 2021, his most popular works were:
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (3062 citations)
- Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes (1062 citations)
- Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial (500 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Myocardial infarction
- Surgery
His scientific interests lie mostly in Internal medicine, Cardiology, Randomized controlled trial, Placebo and Hazard ratio.
Much of his study explores Internal medicine relationship to Gastroenterology.
His work on Coronary artery disease, Atheroma and Myocardial infarction as part of general Cardiology research is frequently linked to Free zone, bridging the gap between disciplines.
In his work, Coronary atherosclerosis is strongly intertwined with Lipoprotein, which is a subfield of Coronary artery disease.
His Placebo research incorporates elements of Tolerability and Endocrinology.
His Hazard ratio study incorporates themes from Surgery and Mace.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
